Improving Cell Therapies to Repair Articular Cartilage Damage
Researchers will evaluate the ability of a unique population of cells called interzone cells to produce new cartilage in horses with joint damage.
Researchers will evaluate the ability of a unique population of cells called interzone cells to produce new cartilage in horses with joint damage.
Researchers will investigate genetic risk factors for equine recurrent uveitis, a common eye condition and leading cause of blindness in horses.
Researchers will investigate how to improve diagnosis and treatment of equine insect bite hypersensitivity, one of the most common allergic skin diseases in horses.
Researchers will validate genetic mutations that may increase the risk of developing osteochondrosis, a developmental orthopedic disease commonly diagnosed in young horses.
The research fellow will evaluate whether stem cells and regenerative therapies can be used for treating horses with brain and spinal cord diseases.
Researchers will identify the gene(s) and underlying mutations that increase risk of recurrent exertional rhabdomyolysis, or tying up, in Thoroughbred and Standardbred horses.
Researchers will evaluate the safety and effectiveness of a vaccine against foal pneumonia caused by the bacterium Rhodococcus equi.